Detalhe da pesquisa
1.
Efficacy of a Cell-Culture-Derived Quadrivalent Influenza Vaccine in Children.
N Engl J Med;
385(16): 1485-1495, 2021 10 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34644472
2.
Meningococcal Serogroup ACWYX Conjugate Vaccine in Malian Toddlers.
N Engl J Med;
384(22): 2115-2123, 2021 06 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34077644
3.
Superior Boosting of Neutralizing Titers Against Omicron SARS-CoV-2 Variants by Heterologous SCB-2019 Vaccine vs a Homologous Booster in CoronaVac-Primed Adults.
J Infect Dis;
228(9): 1253-1262, 2023 11 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37439701
4.
Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial.
Lancet;
399(10323): 461-472, 2022 01 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35065705
5.
Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial.
Lancet;
397(10275): 682-694, 2021 02 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33524311
6.
Persistence of the Immune Responses and Cross-Neutralizing Activity With Variants of Concern Following 2 Doses of Adjuvanted SCB-2019 Coronavirus Disease 2019 Vaccine.
J Infect Dis;
224(10): 1699-1706, 2021 11 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34480575
7.
Comparability of Titers of Antibodies against Seasonal Influenza Virus Strains as Determined by Hemagglutination Inhibition and Microneutralization Assays.
J Clin Microbiol;
58(9)2020 08 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32493784
8.
Interchangeability of different COVID-19 vaccine platforms as booster doses: A phase 3 study mimicking real-world practice.
Vaccine;
2024 May 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38762360
9.
SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines.
Hum Vaccin Immunother;
20(1): 2301632, 2024 Dec 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38206168
10.
Boosting with adjuvanted SCB-2019 elicits superior Fcγ-receptor engagement driven by IgG3 to SARS-CoV-2 spike.
NPJ Vaccines;
9(1): 7, 2024 Jan 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38182593
11.
Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials.
Nat Commun;
15(1): 4081, 2024 May 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38744844
12.
Six-month safety follow-up of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in adults: A phase 2/3, double-blind, randomized study.
Vaccine;
41(13): 2253-2260, 2023 03 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36868877
13.
Immunogenicity of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in SARS-CoV-2-naïve and exposed individuals in a phase 2/3, double-blind, randomized study.
Vaccine;
41(11): 1875-1884, 2023 03 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36781334
14.
Safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit COVID-19 vaccine in healthy 12-17 year-old adolescents.
Hum Vaccin Immunother;
19(1): 2206359, 2023 12 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37226504
15.
Homologous and Heterologous Boosting of the Chadox1-S1-S COVID-19 Vaccine With the SCB-2019 Vaccine Candidate: A Randomized, Controlled, Phase 2 Study.
Open Forum Infect Dis;
9(8): ofac418, 2022 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36043184
16.
Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial.
Lancet Infect Dis;
22(7): 990-1001, 2022 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35447085
17.
Safety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults.
Open Forum Infect Dis;
9(7): ofac206, 2022 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35794943
18.
Rotarix in developing countries: paving the way for inclusion in national childhood immunization programs in Africa.
J Infect Dis;
202 Suppl: S80-6, 2010 Sep 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20684722
19.
Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study.
Lancet Infect Dis;
21(7): 1027-1037, 2021 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33577767
20.
A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults.
Hum Vaccin Immunother;
17(5): 1248-1261, 2021 05 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33121346